These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier. Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371 [TBL] [Abstract][Full Text] [Related]
9. Skin allograft survival following intrathymic injection of donor bone marrow. Cober SR; Randolph MA; Lee WP J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320 [TBL] [Abstract][Full Text] [Related]
10. Influence of gender on allograft rejection in a rat heart transplant model. Takami H; Backer CL; Crawford SE; Zales VR; Mavroudis C J Heart Lung Transplant; 1995; 14(3):529-36. PubMed ID: 7654736 [TBL] [Abstract][Full Text] [Related]
11. Donor cell engraftment in recipient lymphoid tissues after rat limb allograft. Muramatsu K; Kurokawa Y; Ihara K; You-Xin S; Kawai S J Surg Res; 2005 Mar; 124(1):38-44. PubMed ID: 15734477 [TBL] [Abstract][Full Text] [Related]
12. Myeloablative irradiation, granulocyte-colony stimulating factor, and FK506 can induce macrochimerism and prolong the survival of experimental extremity allografts. Muramatsu K; Kato H; Yoshida Y; Moriya A; Okimoto T; Taguchi T J Surg Res; 2011 Dec; 171(2):807-13. PubMed ID: 20538288 [TBL] [Abstract][Full Text] [Related]
13. Recipient immature dendritic cells do not prolong allograft survival. Maksymowicz M; Olszewski WL; Gewartowska M; Kolakowska B Transplant Proc; 2005; 37(1):25-6. PubMed ID: 15808534 [TBL] [Abstract][Full Text] [Related]
14. Lymphocyte chimerism in a full allogeneic composite tissue (rat-limb) allograft model prolonged with cyclosporine. Hewitt CW; Black KS; Henson LE; Achauer BM; Nguyen JH Transplant Proc; 1988 Apr; 20(2 Suppl 2):272-8. PubMed ID: 3259042 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of combining donor-specific presensitization with a simultaneous single injection of tacrolimus on pulmonary allografts. Misao T; Udaka T; Aoe M; Date H; Andou A; Shimizu N J Heart Lung Transplant; 1997 Nov; 16(11):1099-105. PubMed ID: 9402508 [TBL] [Abstract][Full Text] [Related]
16. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells. Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518 [TBL] [Abstract][Full Text] [Related]
17. Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival. Kanatani T; Lanzetta M; Owen E; Matsumoto T; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA Transplant Proc; 2005 Jun; 37(5):2382-4. PubMed ID: 15964421 [TBL] [Abstract][Full Text] [Related]
18. Role of passenger leukocytes in allograft rejection: effect of depletion of donor alveolar macrophages on the local production of TNF-alpha, T helper 1/T helper 2 cytokines, IgG subclasses, and pathology in a rat model of lung transplantation. Sekine Y; Bowen LK; Heidler KM; Van Rooijen N; Brown JW; Cummings OW; Wilkes DS J Immunol; 1997 Oct; 159(8):4084-93. PubMed ID: 9378999 [TBL] [Abstract][Full Text] [Related]
19. Vascularized bone allografts: in vitro assessment of cell-mediated and humoral responses. Innis PC; Randolph MA; Paskert JP; Burdick JF; Clow LW; Yaremchuk MJ; Weiland AJ Plast Reconstr Surg; 1991 Feb; 87(2):315-25. PubMed ID: 1989024 [TBL] [Abstract][Full Text] [Related]
20. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression. Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]